These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32564819)

  • 21. A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.
    Semba CP; Torkildsen GL; Lonsdale JD; McLaurin EB; Geffin JA; Mundorf TK; Kennedy KS; Ousler GW
    Am J Ophthalmol; 2012 Jun; 153(6):1050-60.e1. PubMed ID: 22330307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].
    Lee S; Dausch S; Maierhofer G; Dausch D
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
    Keating GM
    Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensive Therapy.
    Roberti G; Agnifili L; Berardo F; Riva I; Figus M; Manni G; Quaranta L; Oddone F
    Adv Ther; 2018 May; 35(5):686-696. PubMed ID: 29687335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation.
    Carracedo G; Pastrana C; Serramito M; Rodriguez-Pomar C
    Acta Ophthalmol; 2019 Mar; 97(2):e162-e169. PubMed ID: 30280515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Choice of eye drops for the therapy of dry eye].
    Watanabe H
    Nippon Ganka Gakkai Zasshi; 2012 Dec; 116(12):1121-2. PubMed ID: 23379200
    [No Abstract]   [Full Text] [Related]  

  • 27. Dry Eye Syndrome Preferred Practice Pattern®.
    Akpek EK; Amescua G; Farid M; Garcia-Ferrer FJ; Lin A; Rhee MK; Varu DM; Musch DC; Dunn SP; Mah FS;
    Ophthalmology; 2019 Jan; 126(1):P286-P334. PubMed ID: 30366798
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome.
    Chiambaretta F; Doan S; Labetoulle M; Rocher N; Fekih LE; Messaoud R; Khairallah M; Baudouin C;
    Eur J Ophthalmol; 2017 Jan; 27(1):1-9. PubMed ID: 27445067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Pinto-Fraga et al.: Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: a randomized controlled clinical trial (Ophthalmology 2016;123:141-153).
    Estevez J; Pesudovs K
    Ophthalmology; 2017 Feb; 124(2):e14. PubMed ID: 28126079
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of sodium hyaluronate eye drops of different osmolarities in the symptomatic treatment of dry eye patients.
    Milazzo G; Papa V; Aragona P; Russo S; Russo P; Di Bella A
    Adv Exp Med Biol; 2002; 506(Pt B):1233-5. PubMed ID: 12614058
    [No Abstract]   [Full Text] [Related]  

  • 31. [Conservative treatment of dry eye].
    Hefner J; Reinshagen H
    Klin Monbl Augenheilkd; 2014 Nov; 231(11):1093-6. PubMed ID: 25275793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
    Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
    Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).
    Tawfik HA
    Am J Ophthalmol; 2010 Nov; 150(5):757; author reply 757. PubMed ID: 21036218
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.
    Stevenson D; Tauber J; Reis BL
    Ophthalmology; 2000 May; 107(5):967-74. PubMed ID: 10811092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dry eye treatment with acupuncture. A prospective, randomized, double-masked study.
    Nepp J; Wedrich A; Akramian J; Derbolav A; Mudrich C; Ries E; Schauersberger J
    Adv Exp Med Biol; 1998; 438():1011-6. PubMed ID: 9635004
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of corneal nerve density on the response to treatment in dry eye disease.
    Kheirkhah A; Dohlman TH; Amparo F; Arnoldner MA; Jamali A; Hamrah P; Dana R
    Ophthalmology; 2015 Apr; 122(4):662-8. PubMed ID: 25542519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic associations of dry-eye syndrome.
    Kaden I; Mayers M
    Int Ophthalmol Clin; 1991; 31(3):69-88. PubMed ID: 1880003
    [No Abstract]   [Full Text] [Related]  

  • 38. Investigating signs and symptoms in dry eyed patients.
    Williamson J
    Br J Ophthalmol; 1997 Jul; 81(7):522. PubMed ID: 9290359
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial.
    Chen M; Gong L; Sun X; Xie H; Zhang Y; Zou L; Qu J; Li Y; He J
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.